BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32998950)

  • 1. Development of
    Jeske R; Reininger D; Turgu B; Brauer A; Harmel C; Fernández de Larrea-Baz N; Martín V; Moreno V; Kogevinas M; Pollán M; Hoheisel JD; Waterboer T; Butt J; Aragonés N; Hufnagel K
    Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2235-2242. PubMed ID: 32998950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors.
    Lorenzo I; Fernández-de-Larrea N; Michel A; Romero B; Lope V; Bessa X; Moreno V; Martín V; Amiano P; Castilla J; Tardón A; Dierssen-Sotos T; Peiró R; Díaz-Santos M; Navarro C; Jiménez-Moleón JJ; Butt J; Barricarte A; Ruiz I; Molina-de-la-Torre AJ; Casabonne D; Pérez-Gómez B; Kogevinas M; Del Campo R; de Sanjosé S; Pollán M; Waterboer T; Aragonés N
    Eur J Cancer Prev; 2019 Jul; 28(4):294-303. PubMed ID: 30489354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection and markers of gastric cancer risk in Alaska Native persons: a retrospective case-control study.
    Keck JW; Miernyk KM; Bulkow LR; Kelly JJ; McMahon BJ; Sacco F; Hennessy TW; Bruce MG
    Can J Gastroenterol Hepatol; 2014 Jun; 28(6):305-10. PubMed ID: 24945184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer.
    Zhou J; Wang W; Xie Y; Zhao Y; Chen X; Xu W; Wang Y; Guan Z
    PLoS One; 2016; 11(1):e0146521. PubMed ID: 26745502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China.
    Limburg P; Qiao Y; Mark S; Wang G; Perez-Perez G; Blaser M; Wu Y; Zou X; Dong Z; Taylor P; Dawsey S
    J Natl Cancer Inst; 2001 Feb; 93(3):226-33. PubMed ID: 11158192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia.
    Ye W; Held M; Lagergren J; Engstrand L; Blot WJ; McLaughlin JK; Nyrén O
    J Natl Cancer Inst; 2004 Mar; 96(5):388-96. PubMed ID: 14996860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.
    Ekström AM; Held M; Hansson LE; Engstrand L; Nyrén O
    Gastroenterology; 2001 Oct; 121(4):784-91. PubMed ID: 11606491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The U-shaped association between body mass index and gastric cancer risk in the Helicobacter pylori Biomarker Cohort Consortium: A nested case-control study from eight East Asian cohort studies.
    Jang J; Wang T; Cai H; Ye F; Murphy G; Shimazu T; Taylor PR; Qiao YL; Yoo KY; Jee SH; Kim J; Chen SC; Abnet CC; Tsugane S; Zheng W; Shu XO; Pawlita M; Park SK; Epplein M
    Int J Cancer; 2020 Aug; 147(3):777-784. PubMed ID: 31745972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research Group on Prevention of Gastric Carcinoma Among Young Adults.
    Kikuchi S; Crabtree JE; Forman D; Kurosawa M
    Am J Gastroenterol; 1999 Dec; 94(12):3455-9. PubMed ID: 10606302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.
    Fernández-de-Larrea N; Michel A; Romero B; Butt J; Pawlita M; Pérez-Gómez B; Castaño-Vinyals G; Moreno V; Martín V; Amiano P; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Clofent J; Alguacil J; Huerta JM; Jiménez-Moleón JJ; Barricarte A; Molinuevo A; Fernández-Villa T; Casabonne D; Sierra Á; Kogevinas M; de Sanjosé S; Pollán M; Del Campo R; Waterboer T; Aragonés N
    Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28737284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions.
    Plummer M; van Doorn LJ; Franceschi S; Kleter B; Canzian F; Vivas J; Lopez G; Colin D; Muñoz N; Kato I
    J Natl Cancer Inst; 2007 Sep; 99(17):1328-34. PubMed ID: 17728213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
    Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
    Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of cytotoxin-associated gene A positive Helicobacter pylori strains in Changle, an area with very high prevalence of gastric cancer in south China.
    Wong BC; Lam SK; Ching CK; Hu WH; Ong LY; Chen BW; Gao Z; Chen JS; Jiang XW; Hou XH; Lu JY; Wang WH; Ho J; Yuen ST; Lai KC; Kwok E; Hui WM; Covacci A
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1295-302. PubMed ID: 10540043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa.
    Lamarque D; Gilbert T; Roudot-Thoraval F; Deforges L; Chaumette MT; Delchier JC
    Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):721-6. PubMed ID: 10445790
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Varga MG; Wang T; Cai H; Xiang YB; Gao YT; Ji BT; Pawlita M; Waterboer T; Zheng W; Shu XO; Epplein M
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):342-344. PubMed ID: 29263184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.